Status:
COMPLETED
Efficacy of CPPLAI in Laparoscopic Sleeve Gastrectomy Patients
Lead Sponsor:
King Khalid University Hospital
Conditions:
Obesity, Morbid
Pain, Postoperative
Eligibility:
All Genders
16-60 years
Phase:
NA
Brief Summary
The high demand for bariatric surgery due to the increasing prevalence of obesity worldwide necessitate evidence-based clinical pathway such as Enhanced Recovery After Bariatric Surgery (ERABS). The p...
Detailed Description
Obesity is a complex multifactorial disease. The worldwide prevalence of obesity has doubled since 1980 to a level that now almost a third of the world's population is classified as overweight. Laparo...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologist (ASA) physical status I-III
- Age 18-60 years
- Either gender
- Obese patients (BMI \>35 for laparoscopic sleeve gastrectomy
Exclusion
- American Society of Anesthesiologist (ASA) physical status IV
- Patients uncontrolled HTN
- Anticipated difficult intubation
- Allergic to morphine
- Clinically significant neurological, cardiovascular, renal hepatic disease planned for postoperative surgical intensive care (SICU) admission
- History of drug abuse or chronic opioid use
Key Trial Info
Start Date :
December 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04680923
Start Date
December 8 2020
End Date
July 7 2021
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Khalid University Hospital
Riyadh, Saudi Arabia, 7805/11472